Shares of Evolent Health (EVH) have gained 9.4% over the past four weeks to close the last trading session at 33.75,buttherecouldstillbeasolidupsideleftinthestockifshort−termpricetargetsofWallStreetanalystsareanyindication.Goingbythepricetargets,themeanestimateof45.38 indicates a potential upside of 34.5%.The mean estimate comprises 13 short-term price targets with a standard deviation of 7.37.Whilethelowestestimateof34 indicates a 0.7% increase from the current pr ...